Spotlight session: Scientific discoveries through the ages
Unravel the fascinating stories of scientific discoveries that revolutionized diagnostics and healthcare and the impact of patient care.
Tuesday, April 22, 2025, 1 p.m. ET
VITROS® syphilis assay is now available on the VITROS 3600 Immunodiagnostic System and VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
From home to hospital, lab to clinic, we deliver real-time, actionable intelligence powered by industry-leading expertise.
- Celebrate Lab Week 2025
- QuidelOrtho launches Vitros® Syphilis Assay
- Changing lives, one test at a time
Committed to people, planet and products
Learn moreInspiring and leading QuidelOrtho
Learn moreFeatured products
Savanna® Platform
Learn moreQuickVue® Rapid Lateral-Flow Tests
Learn moreVITROS® Systems
Learn moreTriage® System
Learn moreOrtho Vision® Swift Automated Immunohematology System
Learn moreSolana® Molecular Testing Platform
Learn moreSofia® Platform
Learn moreOrtho® Workstation Immunohematology Analyzer
Learn moreOrtho Optix™ Reader
Learn moreLyra® Assays
Learn moreSavanna® Platform
Learn moreQuickVue® Rapid Lateral-Flow Tests
Learn moreVITROS® Systems
Learn moreTriage® System
Learn moreOrtho Vision® Swift Automated Immunohematology System
Learn moreSolana® Molecular Testing Platform
Learn moreSofia® Platform
Learn moreOrtho® Workstation Immunohematology Analyzer
Learn moreOrtho Optix™ Reader
Learn moreLyra® Assays
Learn moreWe are driven to transform diagnostic data into answers, understanding and action for more people in more places every day. Learn how we help you chart the course forward in care.
News & Events
Press Release 02/24/25
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
Press Release 01/13/25
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024
Press Release 12/31/24
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Press Release 12/10/24
QuidelOrtho Announces Appointment of Two Independent Directors to its Board
Press Release 11/19/24
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
Press Release 11/19/24
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
